Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC1399642211;42212;42213 chr2:178635203;178635202;178635201chr2:179499930;179499929;179499928
N2AB1235537288;37289;37290 chr2:178635203;178635202;178635201chr2:179499930;179499929;179499928
N2A1142834507;34508;34509 chr2:178635203;178635202;178635201chr2:179499930;179499929;179499928
N2B493115016;15017;15018 chr2:178635203;178635202;178635201chr2:179499930;179499929;179499928
Novex-1505615391;15392;15393 chr2:178635203;178635202;178635201chr2:179499930;179499929;179499928
Novex-2512315592;15593;15594 chr2:178635203;178635202;178635201chr2:179499930;179499929;179499928
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: Q
  • RefSeq wild type transcript codon: CAA
  • RefSeq wild type template codon: GTT
  • Domain: Ig-90
  • Domain position: 32
  • Structural Position: 47
  • Q(SASA): 0.3789
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
Q/R rs756260320 0.029 0.03 N 0.525 0.15 0.101711395817 gnomAD-2.1.1 4.03E-06 None None None None N None 0 0 None 0 0 None 0 None 0 8.9E-06 0
Q/R rs756260320 0.029 0.03 N 0.525 0.15 0.101711395817 gnomAD-4.0.0 1.50604E-05 None None None None N None 0 0 None 0 0 None 0 0 1.88945E-05 0 1.65744E-05

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
Q/A 0.2919 likely_benign 0.2255 benign -0.657 Destabilizing 0.016 N 0.492 neutral None None None None N
Q/C 0.8561 likely_pathogenic 0.8151 pathogenic -0.089 Destabilizing 0.869 D 0.616 neutral None None None None N
Q/D 0.6503 likely_pathogenic 0.48 ambiguous -0.336 Destabilizing 0.016 N 0.483 neutral None None None None N
Q/E 0.068 likely_benign 0.0598 benign -0.215 Destabilizing None N 0.207 neutral N 0.345485013 None None N
Q/F 0.8126 likely_pathogenic 0.7349 pathogenic -0.235 Destabilizing 0.637 D 0.627 neutral None None None None N
Q/G 0.5781 likely_pathogenic 0.4561 ambiguous -1.018 Destabilizing 0.075 N 0.563 neutral None None None None N
Q/H 0.5127 ambiguous 0.3961 ambiguous -0.613 Destabilizing 0.303 N 0.477 neutral N 0.421034109 None None N
Q/I 0.3889 ambiguous 0.2994 benign 0.274 Stabilizing 0.366 N 0.663 prob.neutral None None None None N
Q/K 0.3282 likely_benign 0.2043 benign -0.38 Destabilizing 0.012 N 0.502 neutral N 0.414398597 None None N
Q/L 0.2418 likely_benign 0.1699 benign 0.274 Stabilizing 0.058 N 0.539 neutral N 0.433416014 None None N
Q/M 0.349 ambiguous 0.3083 benign 0.448 Stabilizing 0.637 D 0.473 neutral None None None None N
Q/N 0.4586 ambiguous 0.3232 benign -0.882 Destabilizing 0.075 N 0.476 neutral None None None None N
Q/P 0.9422 likely_pathogenic 0.8646 pathogenic -0.007 Destabilizing 0.11 N 0.52 neutral N 0.437171695 None None N
Q/R 0.3998 ambiguous 0.2794 benign -0.297 Destabilizing 0.03 N 0.525 neutral N 0.414836254 None None N
Q/S 0.3119 likely_benign 0.2361 benign -1.031 Destabilizing 0.016 N 0.514 neutral None None None None N
Q/T 0.2265 likely_benign 0.1846 benign -0.717 Destabilizing 0.075 N 0.473 neutral None None None None N
Q/V 0.2372 likely_benign 0.187 benign -0.007 Destabilizing 0.075 N 0.555 neutral None None None None N
Q/W 0.8906 likely_pathogenic 0.8393 pathogenic -0.136 Destabilizing 0.869 D 0.62 neutral None None None None N
Q/Y 0.7254 likely_pathogenic 0.6049 pathogenic 0.077 Stabilizing 0.637 D 0.521 neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.